Literature DB >> 14551684

Globular adiponectin upregulates nitric oxide production in vascular endothelial cells.

Y Hattori1, M Suzuki, S Hattori, K Kasai.   

Abstract

AIMS/HYPOTHESIS: Adiponectin, also called ACRP30, is a novel adipose tissue-specific protein that has been shown to improve insulin sensitivity and to exert anti-atherogenic effects. It is known that knockout mice lacking endothelial NO synthase (eNOS) develop hypertension, insulin resistance, hyperlipidaemia, and show augmented ischaemia-reperfusion damage. Thus, we examined whether globular adiponectin activates eNOS to produce NO.
METHODS: To analyze NO production in bovine aortic endothelial cells (BAE), NOx (nitrite and nitrate) was measured in the medium with an automated NO detector/high-performance liquid chromatography system. eNOS activation was assessed by phosphorylation of the enzyme and its activity was evaluated by citrulline synthesis in human umbilical vein endothelial cells (HUVEC). eNOS mRNA and protein expressions in HUVEC were evaluated by Realtime PCR and Western blot analysis.
RESULTS: Gobular adiponectin increased NO production in BAE. It also caused eNOS phosphorylation and potentiated eNOS activity in HUVEC. In addition, globular adiponectin up-regulated the eNOS gene to increase protein expression in HUVEC. CONCLUSION/
INTERPRETATION: Globular adiponectin increases NO production through two mechanisms, namely, by activation of eNOS enzyme activity and via an increase in eNOS expression. Activation and up-regulation of eNOS could explain some of the observed vasoprotective properties of globular adiponectin, as well as its beneficial effects on the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551684     DOI: 10.1007/s00125-003-1224-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin.

Authors:  R Heller; A Unbehaun; B Schellenberg; B Mayer; G Werner-Felmayer; E R Werner
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

2.  Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.

Authors:  R R Shankar; Y Wu; H Q Shen; J S Zhu; A D Baron
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 4.  ACRP30, a new hormone controlling fat and glucose metabolism.

Authors:  Tsu-Shuen Tsao; Harvey F Lodish; Joachim Fruebis
Journal:  Eur J Pharmacol       Date:  2002-04-12       Impact factor: 4.432

5.  Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.

Authors:  H Duplain; R Burcelin; C Sartori; S Cook; M Egli; M Lepori; P Vollenweider; T Pedrazzini; P Nicod; B Thorens; U Scherrer
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

6.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.

Authors:  T Yokota; K Oritani; I Takahashi; J Ishikawa; A Matsuyama; N Ouchi; S Kihara; T Funahashi; A J Tenner; Y Tomiyama; Y Matsuzawa
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

7.  The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

Authors:  Joseph G Yu; Sandrine Javorschi; Andrea L Hevener; Yolanta T Kruszynska; Rodney A Norman; Madhur Sinha; Jerrold M Olefsky
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

8.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.

Authors:  J Fruebis; T S Tsao; S Javorschi; D Ebbets-Reed; M R Erickson; F T Yen; B E Bihain; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

9.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  49 in total

Review 1.  Hypertension in diabetes: the role of the vasculature.

Authors:  Naftali Stern; Yonit Marcus
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

Review 2.  Systemic adiponectin malfunction as a risk factor for cardiovascular disease.

Authors:  Wayne Bond Lau; Ling Tao; Yajing Wang; Rong Li; Xin L Ma
Journal:  Antioxid Redox Signal       Date:  2011-04-20       Impact factor: 8.401

Review 3.  Protective vascular and myocardial effects of adiponectin.

Authors:  Barry J Goldstein; Rosario G Scalia; Xin L Ma
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-25

Review 4.  The blood-brain barrier: connecting the gut and the brain.

Authors:  William A Banks
Journal:  Regul Pept       Date:  2008-04-07

5.  Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice.

Authors:  Xiuping Chen; Hanrui Zhang; Michael A Hill; Cuihua Zhang; Yoonjung Park
Journal:  J Vasc Res       Date:  2016-04-07       Impact factor: 1.934

6.  Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction.

Authors:  W H Wilson Tang; Kevin Shrestha; Wilson Tong; Zeneng Wang; Richard W Troughton; Allen G Borowski; Allan L Klein; Stanley L Hazen
Journal:  Transl Res       Date:  2013-03-13       Impact factor: 7.012

7.  Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop.

Authors:  Sridevi Devaraj; Natalie Torok; Mohan R Dasu; David Samols; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

8.  Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery.

Authors:  Lina Zhao; Weidong Chai; Zhuo Fu; Zhenhua Dong; Kevin W Aylor; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  Circ Res       Date:  2013-03-04       Impact factor: 17.367

Review 9.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

10.  Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes.

Authors:  Iosif Halvatsiotis; Panayoula C Tsiotra; Ignatios Ikonomidis; Anastasios Kollias; Panagiota Mitrou; Eirini Maratou; Eleni Boutati; John Lekakis; George Dimitriadis; Theofanis Economopoulos; Dimitrios T Kremastinos; Sotirios A Raptis
Journal:  Cardiovasc Diabetol       Date:  2010-02-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.